Summary
The Ross Prize in Molecular Medicine was established in conjunction with the Feinstein Institutes for Medical Research and Molecular Medicine to recognize biomedical scientists whose discoveries have transformed how medicine is practiced.
The awardees are mid-career researchers who have significantly impacted the understanding of human disease pathogenesis and/or treatment. Moreover, it is anticipated that they will continue to make profound advances in the general field of molecular medicine.
The 2025 Ross Prize in Molecular Medicine will be awarded to Dr. Jeffrey W. Kelly, PhD for his contributions to the science of protein misfolding and aggregation in disease. His pioneering research has illuminated how proteins fold, misfold and clump in toxic quantities in the body, leading to progressive damage in the nervous and cardiovascular systems.
Dr. Kelly has translated basic understanding of protein folding to create therapeutics designed to prevent disease-causing protein aggregation, including the discovery of the first-in-class small molecule drug called tafamidis.. The Kelly lab is currently developing novel therapeutic strategies for degenerative diseases including Alzheimer’s and Parkinson’s diseases, and for loss-of-function diseases such as lysosomal storage diseases.
Join us in celebrating Dr. Kelly’s innovative, award-winning research on June 4th. The symposium will include an exciting presentation from Dr. Kelly on the integral facets of his work, other exciting lectures, and in-person networking opportunities. Register today to participate in this incredible celebration of scientific innovation.
Sponsors
This symposium is made possible by the generosity of Jack and Robin Ross with support from:
Registration
The event is open for registration.